Vitronectin (Vn) is not only a major adhesive glycoprotein present in
platelets but also regulates proteolytic enzyme cascades, including th
e blood coagulation, fibrinolytic, and complement systems. In human pl
atelet lysates prepared by freeze-thawing or by the addition of nonion
ic detergent, the Vn antigen content was drastically reduced in compar
ison with lysates prepared in tire presence of SDS, suggesting that Vn
is hydrolyzed by platelet-associated enzymes. Exogenously added purif
ied human Vn and Vn present in plasma were also cleaved by these enzym
e systems. Degradation was mediated by a nonsecreted or membrane-assoc
iated protease system that was inhibited by E-64, EDTA, and leu-peptin
but not inhibitors of serine and aspartic proteases, suggesting an in
volvement of calcium-dependent cysteine proteases. Consistently, calpa
statin inhibited the hydrolysis of Vn, suggesting that Vn is a substra
te for calpain. This was confirmed in a purified system. Vn was cleave
d by calpains I and II in a dose- and time-dependent manner, resulting
in defined Vn fragments with similar electrophoretic mobility in comp
arison with those detected in platelet lysates. Functional characteriz
ation of the calpain-hydrolyzed Vn revealed that while the type 1 plas
minogen activator inhibitor binding activity was unchanged, the hepari
n and cell binding functions were destroyed. These results suggest tha
t calpains released upon platelet membrane damage or upon tissue injur
y and necrosis differentially regulate functional domains of the Vn mo
lecule.